Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics
|
June 15, 2017
Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models
Vijay K Siripuram, Daniel F B Wright, Murray L Barclay, et al.
Scientific Reports
|
August 15, 2018
A factor VII-based method for the prediction of anticoagulant response to warfarin
Qing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
Basic & Clinical Pharmacology & Toxicology
|
July 8, 2011
The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic model
Daniel F B Wright, Venkata V Pavan Kumar, Hesham S Al-Sallami, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 27, 2025
A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse Settings
Stephen B Duffull, Daniel F B Wright, Xiao Zhu, et al.
The International Journal of Pharmacy Practice
|
April 13, 2022
Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review
Klarissa A Sinnappah, Sophie L Stocker, Jian Sheng Chan, et al.
Clinical Pharmacokinetics
|
April 15, 2017
A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins
Qing Xi Ooi, Daniel F B Wright, R Campbell Tait, et al.
Pharmacy (Basel, Switzerland)
|
May 15, 2020
Measuring the Development of Therapeutic-Decision-Making Skills by Practicing Pharmacists Undertaking a University-Based Postgraduate Clinical Qualification at Distance
Daniel F B Wright, Stephen B Duffull, Kyle J Wilby, et al.
The New Zealand Medical Journal
|
August 3, 2012
Dabigatran: rational dose individualisation and monitoring guidance is needed
Stephen B Duffull, Daniel F B Wright, Hesham S Al-Sallami, et al.
British Journal of Clinical Pharmacology
|
March 6, 2014
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
Paul K L Chin, Daniel F B Wright, David M Patterson, et al.
Drug Safety
|
August 3, 2019
The Association between Metformin Therapy and Lactic Acidosis
Isabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Journal of Pharmacokinetics and Pharmacodynamics
|
June 15, 2017
Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models
Vijay K Siripuram, Daniel F B Wright, Murray L Barclay, et al.
Scientific Reports
|
August 15, 2018
A factor VII-based method for the prediction of anticoagulant response to warfarin
Qing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
Basic & Clinical Pharmacology & Toxicology
|
July 8, 2011
The influence of dosing time, variable compliance and circadian low-density lipoprotein production on the effect of simvastatin: simulations from a pharmacokinetic-pharmacodynamic model
Daniel F B Wright, Venkata V Pavan Kumar, Hesham S Al-Sallami, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 27, 2025
A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse Settings
Stephen B Duffull, Daniel F B Wright, Xiao Zhu, et al.
The International Journal of Pharmacy Practice
|
April 13, 2022
Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review
Klarissa A Sinnappah, Sophie L Stocker, Jian Sheng Chan, et al.
Clinical Pharmacokinetics
|
April 15, 2017
A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins
Qing Xi Ooi, Daniel F B Wright, R Campbell Tait, et al.
Pharmacy (Basel, Switzerland)
|
May 15, 2020
Measuring the Development of Therapeutic-Decision-Making Skills by Practicing Pharmacists Undertaking a University-Based Postgraduate Clinical Qualification at Distance
Daniel F B Wright, Stephen B Duffull, Kyle J Wilby, et al.
The New Zealand Medical Journal
|
August 3, 2012
Dabigatran: rational dose individualisation and monitoring guidance is needed
Stephen B Duffull, Daniel F B Wright, Hesham S Al-Sallami, et al.
British Journal of Clinical Pharmacology
|
March 6, 2014
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
Paul K L Chin, Daniel F B Wright, David M Patterson, et al.
Drug Safety
|
August 3, 2019
The Association between Metformin Therapy and Lactic Acidosis
Isabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.
Page
of 7